AUTOLOGOUS VERSUS HAPLOIDENTICAL DONOR STEM CELL TRANSPLANTATION FOR FAVORABLE-AND INTERMEDIATERISK ACUTE MYELOID LEUKEMIA IN FIRST REMISSION AND UNDETECTABLE MINIMAL RESIDUAL DISEASE: A MULTI-CENTER, PROSPECTIVE STUDY

被引：0
|
作者：
Ding, Yiyang [1 ]
Ru, Yuhua [1 ]
Zhu, Jinjin [1 ]
Zhang, Xi [2 ]
Liu, Lin [3 ]
Jiang, Erlie [4 ]
Huang, He [5 ]
Wang, Jishi [6 ]
Hu, Jiong [7 ]
Zhang, Yanming [8 ,9 ]
Xu, Yajing [10 ]
Yang, Mingzhen [11 ]
Chen, Jia [1 ]
Wu, Depei [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[5] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
[6] Guizhou Med Univ, Affiliated Hosp, Guiyang, Peoples R China
[7] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Natl Res Ctr Translat Med Shanghai, Ruijin Hosp,Sch Med,Shanghai Inst Hematol, Shanghai, Peoples R China
[8] Xuzhou Med Coll, Huaian Hosp, Huaian, Peoples R China
[9] Huaian Second Peoples Hosp, Huaian, Peoples R China
[10] Cent South Univ, XiangYa Hosp, Changsha, Peoples R China
[11] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P001
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [41] Prognostic impact of minimal residual disease assessed by immunophenotype in patients with acute myeloid leukemia undergoing autologous stem cell transplantation.
    Lahuerta, JJ
    Montalban, MA
    Grande, C
    Larregla, S
    Toscano, R
    Ortiz, MC
    Martín, ML
    Bornstien, R
    de la Serna, J
    BLOOD, 1998, 92 (10) : 367B - 367B
  • [42] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
    Kim, A. S.
    Kressin, M. K.
    Mosse, C. A.
    Seegmiller, A.
    LABORATORY INVESTIGATION, 2012, 92 : 347A - 347A
  • [43] Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Saraceni, Francesco
    Labopin, Myriam
    Gorin, Norbert Claude
    Blaise, Didier
    Tabrizi, Reza
    Volin, Liisa
    Cornelissen, Jan
    Cahn, Jean-Yves
    Chevallier, Patrice
    Craddock, Charles
    Wu, Depei
    Huynh, Anne
    Arcese, William
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2015, 126 (23)
  • [44] Post Stem Cell Transplantation Monitoring in Acute Myeloid Leukemia by Markers of Minimal Residual Disease and Engraftment
    Kim, A. S.
    Kressin, M. K.
    Mosse, C. A.
    Seegmiller, A.
    MODERN PATHOLOGY, 2012, 25 : 347A - 347A
  • [45] Autologous peripheral blood stem cells transplantation in patients with acute myeloid leukemia in first complete remission: a single center experience
    Cagirgan, S
    Pehlivan, M
    Donmez, A
    Tombuloglu, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S178 - S178
  • [46] Haploidentical Versus Cord Blood Stem Cell Transplantation As the Second Transplant for Relapsed Acute Myeloid Leukemia Patients after the First Stem Cell Transplantation
    Lee, Jong Hyuk
    Kwag, Daehun
    Kim, Tong-Yoon
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yahng, Seung-Ah
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Yoon, Jae-Ho
    Cho, Byung Sik
    Kim, Yoo-Jin
    Eom, Ki-Seong
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    BLOOD, 2021, 138 : 1849 - +
  • [47] Busulphan and idarubicin as conditioning regimen for autologous stem cell transplantation in patients with acute myeloid leukemia in first or subsequent remission
    Ferrara, F
    Annunziata, M
    Copia, C
    Palmieri, S
    Pollio, F
    Schiavone, EM
    Mele, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S88 - S88
  • [48] Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission
    Konova, Zoya V.
    Parovichnikova, Elena N.
    Galtseva, Irina V.
    Kapranov, Nikolay M.
    Davydova, Julia O.
    Drokov, Mikhail Yu.
    Nareyko, Maria V.
    Popova, Natalia N.
    Dmitrova, Anna A.
    Maslikova, Ulyana V.
    Starikova, Olga S.
    Usikova, Ekaterina I.
    Mikhaltsova, Ekaterina D.
    Koroleva, Olga M.
    Vasilyeva, Vera A.
    Lobanova, Tatiana I.
    Kuzmina, Larisa A.
    Savchenko, Valeriy G.
    BLOOD, 2019, 134
  • [49] Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: The BGMT 87 study
    Reiffers, J
    Stoppa, AM
    Attal, M
    Michallet, M
    Marit, G
    Blaise, D
    Huguet, F
    Corront, B
    ConyMakhoul, P
    Gastaut, JA
    Laurent, G
    Molina, L
    Broustet, A
    Maraninchi, D
    Pris, J
    Hollard, D
    Faberes, C
    LEUKEMIA, 1996, 10 (12) : 1874 - 1882
  • [50] Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges
    Capria, Saveria
    Trisolini, Silvia Maria
    Diverio, Daniela
    Minotti, Clara
    Breccia, Massimo
    Cartoni, Claudio
    Carmini, Daniela
    Gozzer, Maria
    La Rocca, Ursula
    Bafti, Mahnaz Shafii
    Martelli, Maurizio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (04) : 586 - 593
12345